These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9426488)

  • 1. Long-term remission of HIV-associated thrombocytopenia parallels ongoing suppression of viral replication.
    Zell SC; Peterson K
    West J Med; 1997 Dec; 167(6):433-5. PubMed ID: 9426488
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic interventions in primary HIV infection.
    Kinloch-de Loës S; Perrin L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S69-76. PubMed ID: 8595514
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic thrombocytopenic purpura as a clinical manifestation of HIV infection].
    Elezović I; Jevtović Dj; Rolović Z
    Srp Arh Celok Lek; 1989; 117(7-8):499-506. PubMed ID: 2595474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful zidovudine therapy for HIV-related severe thrombocytopenia. Report of a sustained remission.
    Peña JM; Arnalich F; Barbado FJ; Dominguez A; Mostaza J; Valencia ME; Vazquez JJ
    Acta Haematol; 1990; 83(2):86-8. PubMed ID: 2106201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
    Torti C; Barnes E; Quiros-Roldan E; Puoti M; Carosi G; Klenerman P
    Antivir Ther; 2004 Feb; 9(1):139-42. PubMed ID: 15040546
    [No Abstract]   [Full Text] [Related]  

  • 6. Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison.
    Scaradavou A; Cunningham-Rundles S; Ho JL; Folman C; Doo H; Bussel JB
    Am J Hematol; 2007 May; 82(5):335-41. PubMed ID: 17154377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired amegakaryocytic thrombocytopenic purpura treated with intravenous immunoglobulins].
    El Omri H; Skouri H; Kraiem I; Latiri A; Khelif A; Korbi S; Ennabli S
    Ann Med Interne (Paris); 2000 May; 151(3):223-6. PubMed ID: 10896976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal epidural lipomatosis in a human immunodeficiency virus-positive patient receiving steroids and protease inhibitor therapy.
    Ebright JR; Stellini MA; Tselis AC
    Clin Infect Dis; 2001 Mar; 32(5):E90-1. PubMed ID: 11229864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early antiretroviral combination therapy--standard today and tomorrow].
    Dtsch Med Wochenschr; 1997 Mar; 122(11 Suppl):1-4. PubMed ID: 9102288
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in HIV/AIDS therapy.
    Johnson SC; Gerber JG
    Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitors: implications for HIV research and treatment.
    Churchill SA
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):13-8. PubMed ID: 11363325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term suppression of HIV replication in patients with sustained benefit on zidovudine monotherapy.
    Gómez-Cano M; Soriano V; Pérez-Olmeda M; Machuca A; Rodríguez-Rosado R; Valencia E; Moreno V; Gutiérrez M; González-Lahoz J
    AIDS; 1998 May; 12(8):964-6. PubMed ID: 9631158
    [No Abstract]   [Full Text] [Related]  

  • 14. Use and access to viral load measure assays: the need for validation.
    Agosto M
    Update Natl Minor AIDS Counc; 1995; ():7-8. PubMed ID: 11362791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 plus HAART reduces HIV in immune system "hiding places".
    WORLD; 1998 Dec; (No 92):7. PubMed ID: 11365976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella pneumonia with immune thrombocytopenic purpura: a patient with multiple complications.
    Umstattd LJ; Reichenberg JS
    Cutis; 2008 Dec; 82(6):399-402. PubMed ID: 19181029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the principles of anti-HIV drug therapy.
    Horn T
    Surviv News (Atlanta Ga); 2001 Jul; ():13. PubMed ID: 11683014
    [No Abstract]   [Full Text] [Related]  

  • 18. Eradication timetable setback.
    TreatmentUpdate; 1999 May; 11(3):3-4. PubMed ID: 11366780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AIDS. Therapeutic approaches in the control of HIV infection].
    Müller WE; Schröder HC
    Med Monatsschr Pharm; 1990 May; 13(5):141-6. PubMed ID: 2192245
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic drugs--rarely causal therapy].
    Uhl D
    Med Monatsschr Pharm; 1990 May; 13(5):129. PubMed ID: 2192241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.